The FDA’s new support of a single study approach has drawn much discussion, raising questions as to whether conducting just one confirmatory study is a risky position for sponsors to take. In this blog, Andrew Garrett,...
From innovation to implementation: Navigating neurologic monoclonal antibody development
Read the whitepaperMaking sense of the rapidly changing biosimilars landscape
Strategies for adapting and achieving optimal market access
Read the whitepaperBuilding a comparative evidence base using network meta-analysis
Methods, implementation and reporting
Read the whitepaperDownload Global and China biotech survey reports
Two new survey reports of 260+ Global and China-based biotech leaders are ready to download
Get your copy now
Featured solutions
EngageAI
Our voice of the customer feedback platform has been enhanced using AI; transforming how we listen, respond, and act on your feedback.
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
PV
regulatory intelligence
Stay compliant throughout any local or global regulatory change.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
Oncology
Explore how ICON supports oncology development with faster start‑up and predictable delivery.
Webinars
Insights into first-in-human study design of oligonucleotide
27 May 2026. Register now.
When patients lead: Breaking barriers in ultra-rare disease drug development
Watch the webinar.
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.
